Postoperative 20% Albumin Infusion and Acute Kidney Injury in High-Risk Cardiac Surgery Patients
Join the next Breakthroughs in blood: Advancements into action webinar and panel discussion led by Dr. Yahya Shehabi, who will be discussing his recent publication, Postoperative 20% Albumin Infusion and Acute Kidney Injury in High-Risk Cardiac Surgery Patients: The ALBICS AKI Randomized Clinical
Jun 9 12:00 pm | Toronto/Virtual
Journal Club
Presented by Dr. Alex Dotto MD, Physician Trainee Canadian Blood Services Learning objectives TBA Registration TBA Appraisal TBA To be added to the distribution list for the LearnTransfusion series, send an email to learn.transfusion@blood.ca with “Weekly Transfusion Medicine Seminars” in the
May 19 12:00 pm | Toronto/Virtual
Journal Club: Pathogen-Reduced Red Blood Cells in Cardiac Surgery: The ReCePI Trial
Presented by Dr. Naif Muhannaa MD, Physician Trainee Canadian Blood Services Learning objectives Describe the rationale for pathogen-reduced red blood cells. Explain the clinical question and design of the ReCePI trial. Interpret the main efficacy and safety findings of the trial. Critically
May 12 12:00 pm | Toronto/Virtual
Journal Club: Whole Blood, Whole Story? Evidence from the SWiFT UK Trial
Presented by Dr. Nicole Relke MD, Physician Trainee Canadian Blood Services Learning objectives Describe the rationale for prehospital whole blood transfusion in traumatic hemorrhage. Critically appraise the design, strengths, and limitations of the SWiFT UK trial. Discuss the implications of the
Countdown to CSTM 2026: Agenda contributors
The Canadian Society for Transfusion Medicine (CSTM) annual conference, held in partnership with Canadian Blood Services and Héma-Québec, is taking place June 4-7 in Hamilton, ON.Each year, the CSTM conference provides opportunity for health-care professionals in transfusion medicine to share knowledge, learn about recent advancements in transfusion medicine, and connect with colleagues from across the country.In the lead-up to the event, we invited members of Canadian Blood Services’ research and education network to share previews of their contributions to this year’s exciting agenda. Below
April 28, 2026
Jun 8 8:00 am | Virtual
Patient, Family, Donor Research Forum
Patient, Family, Donor Research Forum The theme of the PFD forum is “Pathways for Partnership: Centring Indigenous Priorities in Donation and Transplant Systems”. The program will bring together Indigenous and non-Indigenous national and international speakers, including persons with lived
Dec 1 8:00 am | Edmonton, AB / Hybrid
CDTRP 2026 Scientific Meeting
The Canadian Donation and Transplantation Research Program Save the date! The CDTRP 2026 Scientific Meeting (Edmonton, hybrid, December 1-2) will convene Canada’s national donation and transplantation research community to share new and emerging research, center patient, family, and donor partner
Apr 28 12:00 pm | Toronto/Virtual
Topic: Updates to the ISBT Blood Group Database for Clinical Transfusion Medicine
Presented by Dr. Sheharyar Raza MD, FRCPC Canadian Blood Services Learning objectives Understand the basics of genotyping nomenclature in the ISBT table Learn to use the new digitized ISBT BG database for clinical case interpretation Gain basic familiarity with genome browsers and navigating them
Apr 14 12:00 pm | Toronto/Virtual
Journal Club: Thromboelastography or rotational thromboelastometry guided algorithms in bleeding patients
Presented by Dr. Ali Tabatabaey MD, Physician Trainee Canadian Blood Services Learning objectives Review VET guided treatment algorithms and their impact based on appraisal of the paper. Additional Reference Material: Article 1 Article 2 Registration Click here to register Appraisal Click here for
Apr 7 12:00 pm | Toronto/Virtual
Topic: Interesting inherited and acquired bleeding cases
Presented by Dr. Shannon Jackson MD, FRCPC West Coast Hematology Learning objectives Review the approach to bleeding in acquired bleeding disorders Discuss the considerations for bleeding when patients with inherited hemophilia A or B are taking novel therapies Discuss the management of bleeding in
